| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.65M | 54.02M | 54.69M | -67.73M | 169.09M | 49.91M |
| Gross Profit | 37.13M | 37.68M | 37.89M | -83.46M | 157.83M | 40.02M |
| EBITDA | 30.70M | 30.72M | 30.82M | 0.00 | 0.00 | 28.07M |
| Net Income | 40.95M | 37.32M | -4.79M | -98.28M | 146.99M | 33.80M |
Balance Sheet | ||||||
| Total Assets | 756.90M | 764.64M | 773.92M | 792.56M | 895.81M | 712.47M |
| Cash, Cash Equivalents and Short-Term Investments | 53.59M | 35.32M | 19.77M | 20.05M | 38.55M | 23.36M |
| Total Debt | 211.06M | 211.21M | 228.82M | 225.46M | 219.54M | 165.47M |
| Total Liabilities | 229.33M | 231.26M | 249.44M | 244.93M | 238.68M | 184.27M |
| Stockholders Equity | 527.57M | 533.38M | 524.48M | 547.62M | 657.13M | 528.20M |
Cash Flow | ||||||
| Free Cash Flow | 22.22M | 24.91M | 20.20M | 23.02M | 20.01M | 18.30M |
| Operating Cash Flow | 22.23M | 24.92M | 20.21M | 23.03M | 20.01M | 18.57M |
| Investing Cash Flow | 44.27M | 37.69M | -4.46M | -26.76M | -33.83M | -1.30M |
| Financing Cash Flow | -41.14M | -47.07M | -16.02M | -14.59M | 29.01M | -17.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £57.96M | 4.85 | 10.22% | 8.23% | 8.48% | 207.85% | |
72 Outperform | £375.52M | 3.34 | 11.57% | 7.17% | 1.60% | 211.81% | |
71 Outperform | £158.99M | 9.16 | 7.37% | 7.43% | -10.95% | -30.09% | |
67 Neutral | £236.48M | 5.97 | 9.81% | 6.64% | ― | ― | |
66 Neutral | £38.22M | 54.66 | 4.33% | 7.14% | -41.22% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | £393.24M | 6.81 | 7.51% | 5.15% | -3.98% | 412.08% |